When was Noble Biomaterials founded?

Noble Biomaterials was founded in 2005 and raised its 1st funding round 2 years after it was founded.

Where is Noble Biomaterials located?

Noble Biomaterials is headquartered in United States. It is registered at Scranton, Pennsylvania.

How many employees does Noble Biomaterials have?

As of Mar 31, 2026, the latest employee count at Noble Biomaterials is 122.

Is Noble Biomaterials a funded company?

Noble Biomaterials is a funded company, having raised a total of $8.01M across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 09, 2007.

When was the latest funding round of Noble Biomaterials?

Noble Biomaterials' latest funding was a $***** Conventional Debt round on Oct 19, 2021, with participation from 1 investor. Its primary sector is Advanced Materials. In United States, the Advanced Materials sector has seen $462M in funding in 2026 to date.

Where does Noble Biomaterials rank among its competitors?

Noble Biomaterials ranks 7th amongst 32 active competitors, of which 8 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Advanced Silicon Group, which secured $200K in May, 2024.

Who are the top competitors of Noble Biomaterials?

Noble Biomaterials' top competitors include Nanogap, Cambrios and Advanced Silicon Group. Among them, Advanced Silicon Group secured the most recent funding round in May, 2024.

Noble Biomaterials - 2026 Company Profile, Team, Funding & Competitors

Company Details

Intelligent materials company providing antimicrobial and conductive solutions across diverse industries. They develop and manufacture advanced materials that enhance products in life and style, health and medical, electronics and industrial, and aerospace and defense sectors. Their core focus lies in creating intelligent materials with antimicrobial and conductive properties, offering solutions for infection prevention, odor control, and enhanced performance. They serve as a critical supplier to the US Military, healthcare industry, and various commercial partners, providing essential components for diverse applications. They are registered as a medical device manufacturing facility and are committed to innovation, research, and development to meet the evolving needs of their customers. Their products contribute to safety, hygiene, and advanced technological applications across multiple sectors.

Website: noblebiomaterials.com
Social
Email ID: *****@noblebiomaterials.com
Registered Address: Scranton, Pennsylvania

Key Metrics

Founded Year

2005

Location

United States

Stage

Series C

Total Funding

$8.01M in 5 rounds

Latest Funding Round

Conventional Debt, Oct 19, 2021, $*****

Investors

DuPont & 5 more

Ranked

7^th among 32 active competitors

Employee Count

122 as on Mar 31, 2026

Investment & Acquisitions

Carolina Silver

Similar Companies

Nanogap & 19 more

View Noble Biomaterials' full profile

Noble Biomaterials is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NOBLE BIOMATERIALS, INC CIN: 202337965 , United States, Active	Dec 31, 1999	-	112 (As on Dec 31, 2019)	-

Noble Biomaterials has raised a total funding of $8.01M over 5 rounds. Its first funding round was on Aug 09, 2007. Its latest funding round was a Conventional Debt round on Oct 19, 2021 for $*****. 1 investor participated in its latest round. Noble Biomaterials has 6 institutional investors.

Here is the list of recent funding rounds of Noble Biomaterials:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 19, 2021	5849002	Conventional Debt	6343489	1077434	4308254	7150763
Jul 2013	4492139	Series C	9705676	8527357	4256876	Rittenhouse Ventures
Feb 10, 2012	9431195	Series B	1679465	3130654	6733219	Northwater Capital Management & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Noble Biomaterials's funding rounds and investors

The founders of Noble Biomaterials is Joel Furey.

Here are the details of Noble Biomaterials' key team members:

Joel Furey: Founder & Chief Commercial Officer of Noble Biomaterials.

View details of Noble Biomaterials's Founder profiles and Board Members

Noble Biomaterials' employee count trend

Noble Biomaterials has 122 employees as of Mar 26. Here is Noble Biomaterials's employee count trend over the years:

Employee count trend for Noble Biomaterials

Uncover Noble Biomaterials' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Noble Biomaterials include Nanogap, Cambrios and Advanced Silicon Group. Here is the list of Top 10 competitors of Noble Biomaterials, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nanogap 2006, Santiago de Compostela (Spain), Series A	Manufactures silver-based nanomaterials	$2.78M	EIC Fund, Caixa Capital Risc & 4 others	47/100
2nd	Cambrios 2004, Sunnyvale (United States), Series D	Silver nanowire solutions to enable electronic devices and transparent conductor development	$63.4M	Samsung Venture Investment, Avalon Ventures ... & 14 others	44/100
3rd	Advanced Silicon Group 2015, Boston (United States), Seed	Innovating biosensor technology for faster, cheaper, and multiplexed protein analysis	$1.03M	MassVentures, Home Run Ventures & 3 others	43/100
4th	Plextronics 2002, Pittsburgh (United States), Acquired	Developer of conductive polymers and inks for electronic printing	$59.3M	Solvay, Applied Materials & 10 others	41/100
5th	Innova Dynamics 2008, San Francisco (United States), Acquired	Innova Dynamics: Surface innovation through transparent conductive films and inks	$5.5M	Rho Capital Partners, MentorTech Ventures ... & 3 others	38/100
6th	Shenzhen Huake Chuangzhi Technology 2014, Shenzhen (China), Series C	Developer of silver nanowire technology and products	$14.4M	Shenzhen Capital Group, Greater Bay Area Homeland Investments ... & 2 others	38/100
7th	Noble Biomaterials 2005, United States, Series C	Intelligent materials company providing antimicrobial and conductive solutions across diverse industries	$8.01M	DuPont, TL Ventures & 4 others	37/100
8th	Cima NanoTech 2003, Oakdale (United States), Series C	Patented silver nanoaparticle-based conductive films for large format touch screens	$28.4M	Masa Life Science Fund, Millennium Materials Technologies Fund ... & 1 others	34/100
9th	Quantum Opus 2013, Plymouth (United States), Unfunded	Superconducting single-photon detection systems for quantum optics and related applications	-	-	31/100
10th	S Nanotech 2017, Kota Kinabalu (Malaysia), Unfunded	Developer of nanomaterial for application in touch panels	-	-	30/100